CA Patent

CA3165636A1 — Methods for treating parkinson's disease with sepiapterin

Assigned to PTC Therapeutics MP Inc · Expires 2021-07-29 · 5y expired

What this patent protects

The present invention features methods for treating Parkinson's disease using sepiapterin, or a pharmaceutically acceptable salt thereof.

USPTO Abstract

The present invention features methods for treating Parkinson's disease using sepiapterin, or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Sephience (SEPIAPTERIN) · Ptc Therap

Patent Metadata

Patent number: CA3165636A1
Jurisdiction: CA
Classification: —
Expires: 2021-07-29
Drug substance claim: No
Drug product claim: No
Assignee: PTC Therapeutics MP Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.